Masamichi Mizuma
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 81
- Cancer Cells and Metastasis 8
- Molecular Medicine top 5%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 21
- Aging top 10%
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 25
- Pancreatitis Pathology and Treatment 23
-
- Neuroendocrine Tumor Research Advances 22
-
- Renal cell carcinoma treatment 11
- Gallbladder and Bile Duct Disorders 8
- Co-authors
- Michiaki UnnoFuyuhiko MotoiKei NakagawaTakanori MorikawaAnirban MaitraHiroki HayashiHideo OhtsukaTatsuo Hata
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Masamichi Mizuma
115 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 102
- Oncology 917
- Molecular Medicine 149
- Cancer Research 370
- Aging 28
- Surgery 560
Countries citing papers authored by Masamichi Mizuma
This map shows the geographic impact of Masamichi Mizuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masamichi Mizuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masamichi Mizuma more than expected).
Fields of papers citing papers by Masamichi Mizuma
This network shows the impact of papers produced by Masamichi Mizuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masamichi Mizuma. The network helps show where Masamichi Mizuma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masamichi Mizuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 18 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2012 | 72 | |
| 18 | 2011 | 156 | |
| 19 | 2011 | 0 | |
| 20 | 2010 | 169 |
About Masamichi Mizuma
Masamichi Mizuma is a scholar working on Oncology, Cancer Research, Surgery, Hepatology and Pulmonary and Respiratory Medicine, having authored 130 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (81 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Pancreatitis Pathology and Treatment (23 papers), Neuroendocrine Tumor Research Advances (22 papers), Cancer Genomics and Diagnostics (21 papers), Renal cell carcinoma treatment (11 papers), Cancer Cells and Metastasis (8 papers) and Gallbladder and Bile Duct Disorders (8 papers). The work is most often cited by research in Oncology (917 citations), Molecular Medicine (149 citations), Cancer Research (370 citations), Aging (28 citations) and Surgery (560 citations). Masamichi Mizuma has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Michiaki Unno, Fuyuhiko Motoi, Kei Nakagawa, Takanori Morikawa, Anirban Maitra, Hiroki Hayashi, Hideo Ohtsuka, Tatsuo Hata, Masaharu Ishida and Takeshi Naitoh. Their work appears in journals such as Surgery Today, Pancreatology, Pancreas, Cancer Science and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.